Anderson Financial Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-645
Closed -$16.3K 156
2025
Q1
$16.3K Hold
645
0.01% 143
2024
Q4
$17.1K Buy
+645
New +$17.5K 0.01% 80

Other funds holding PFE

Anderson Financial Strategies's PFE Position: Q2 2025 in Review

Anderson Financial Strategies sold out of Pfizer (PFE) in Q2 2025, closing a stake of 645 shares — an estimated $16.3K sold.

Anderson Financial Strategies first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $17.1K in Q4 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Anderson Financial Strategies reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Anderson Financial Strategies sold 645 Pfizer shares in Q2 2025, an estimated $16.3K.
  • Anderson Financial Strategies first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
  • Anderson Financial Strategies's Pfizer position peaked at $17.1K in Q4 2024.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Anderson Financial Strategies's 13F filing for Q2 2025, filed 11 Aug 2025.